Free-cash-flow proxy increased 20.4%
Free-cash-flow proxy changed +20.4% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Free-cash-flow proxy changed +20.4% from the comparable as-filed period.
Debt / revenue changed +1631 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Gross margin changed +107 basis points from the comparable as-filed period.
Current liabilities changed -23.5% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Capital expenditure changed +113.3% from the comparable as-filed period.
Debt / assets changed +358 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Capex / revenue changed +188 basis points from the comparable as-filed period.
Operating cash-flow margin changed +431 basis points from the comparable as-filed period.
Revenue changed -1.3% from the comparable as-filed period.
Free-cash-flow margin changed +244 basis points from the comparable as-filed period.
Shares outstanding changed +0.1% from the comparable as-filed period. The change ranks at the 25th percentile of 8 prior comparable changes. This reverses 8 consecutive comparable moves in the opposite direction.
Total assets changed +1.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Stock-based compensation changed -10.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
SBC / revenue changed -9 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Selling, general & administrative changed +9.3% from the comparable as-filed period.
Inventory changed +4.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
R&D / revenue changed +56 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Cost of revenue changed -2.7% from the comparable as-filed period.
Net debt changed +1.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Gross profit changed +3.2% from the comparable as-filed period.
Debt / revenue changed +1034 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Cash / debt changed +1136 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Revenue changed -8.0% from the comparable as-filed period.
Capital expenditure changed +42.1% from the comparable as-filed period.
Operating margin changed +75 basis points from the comparable as-filed period.
Inventory changed +11.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Cost of revenue changed -11.0% from the comparable as-filed period.
Capex / revenue changed +99 basis points from the comparable as-filed period.
Reported total debt changed +10.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Gross debt changed +10.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Debt / assets changed +181 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Operating income changed +1.3% from the comparable as-filed period.
Shares outstanding changed -0.0% from the comparable as-filed period. The change ranks at the 0th percentile of 8 prior comparable changes.
Operating cash-flow margin changed +167 basis points from the comparable as-filed period.
R&D / revenue changed +61 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Total assets changed -2.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Current assets changed +1.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Gross profit changed +2.1% from the comparable as-filed period.
Net debt changed -2.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Free-cash-flow margin changed +67 basis points from the comparable as-filed period.
Selling, general & administrative changed -6.1% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.